NetScientific portfolio company Vortex enters manufacturing partnership with STRATEC
The firm said STRATEC would assist Vortex in producing a customised chip, a crucial component of its VTX-1 liquid biopsy platform
Company
LON:NSCI
EMV Capital plc is a deep tech and life sciences venture capital investment group with an international portfolio of high-growth companies. With a strategic focus on generating superior returns for investors from the fast-growing sectors and technologies that will define our future, the group invests in, manages, and strengthens early stage IP-rich companies.
424 stories · page 3 of 5
The firm said STRATEC would assist Vortex in producing a customised chip, a crucial component of its VTX-1 liquid biopsy platform
The bank suggested there could be a faster pace of hikes if the UK gets a smooth Brexit deal
Upon satisfaction of the contingent outbound direct investment approval, NetScientific's controlling interest will be 50.4% of Glycotest, calculated on a fully-diluted basis following the closing of the Series A Financing
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Some of the main news-driven risers and fallers in London on Monday …
The UK's premier index of leading shares closed down seven points, or 0.10% at 7,042
In its recent half-year results, the medical research investor recorded a loss after tax of £4.6mln in the six months ended June 30, less than the £5.2mln loss a year ago
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
“We are pleased with the progress our portfolio companies have made in the first half of this year, and expect several key value inflection points to occur in the next 12 months”
FTSE 100 closed the day 35 points lower as the situation in Italy rattled markets
A look at some of the biggest risers and fallers in the UK market on Thursday.
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
The BRIDGE study, funded by the European Respiratory Society, will be conducted over three years and involve 1,000 patients suffering from bronchiectasis across Europe
The UK's premier index closed up around 36 points at 7,367.
Investments and investor services
A look at the day's big share price movers, featuring EVR Holdings, DeepMatter, Versarien, Hikma Pharma, Debenhams, Nanoco, IndigoVision, Premier Veterinary Group and Feedback
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Wanda’s technology uses machine learning to help healthcare providers better manage the risk and care of patients by predicting adverse events before they happen
Investments and investor services
Footsie closed down 1.49%, or around 114 points, at 7,497 on the day
A look at some of the top risers and fallers in London today
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
The investment firm said the mark, registered for ProAxsis' ProteaseTag Active Proteinase-3 Immunoassay, was accompanied by a first commercial sale of around £5,000
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Companies covered today include 88 Energy, Bagir Group, Future, Mpac, NAHL, Quadrise Fuels and Smiths Group
The AIM-listed firm said the use of Wanda’s existing platform had been shown to predict 90% of patient-level adverse events up to seven days in advance of their occurrence and allows for virtual intervention to prevent such events
Investments and investor services
The index of leading UK shares closed up just shy of 50 points higher at 7,676, while the FTSE 250 was also up
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the biggest risers and fallers in London on Wednesday
NetScientific said Bob Englert, who is currently chief technology officer, takes up the position with immediate effect, replacing Gene Walther
The UK's premier index added over 25 points at 7,712, with resource stocks taking up four of the top five positions.
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the biggest risers and fallers in London on Monday
Investments and investor services
In the currency market, sterling was down 0.48% against the Euro, while it lost 0.28% against the US dollar.
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at the day's major share price movements, featuring MySQUAR, Velocity Composites, Magnolia Petroleum and Dignity
The healthcare IP commercialisation group said the project will assist in the clinical validation of new therapeutics for deubiquitinases (DUBs) as part of a £150,000 project
The UK blue-chip index finished at 7,701 - up 0.31%, but was down on the week, off around 0.46%. .
Some of the main news-driven risers and fallers on Monday afternoon...
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Wanda’s patient monitoring technology led to the number of congestive heart failure patients being readmitted to hospital almost halving
Investments and investor services
FTSE 100 reached a new record close on Monday after achieving it last time on Thursday
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at some of the biggest risers and fallers in London on Wednesday.
The company said its portfolio company ProAxsis would present data on its NEATstik test to the ATS conference which is to take place between May 19-24
Investments and investor services
The FTSE 100 continued higher on Wednesday, extending the week's winning streak.
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Polymetal has acquired an 85% stake in one copper-gold deposit, sold an 85% in another copper-gold project, and it has also upped its stake in a silver property
The transatlantic healthcare IP commercialisation group said the studies support the use of Vortex's non-invasive technology in the characterisation of circulating tumour cells (CTCs) for important clinical biomarkers, namely EGFR and PD-L1
The FTSE 100 closed below the 7,200 level as sterling continues to strengthen against the dollar
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Builders and building materials
A look at some of the biggest risers and fallers in London on Thursday
A placing at 52.5p will raise £5mln, with the possibility of a further £1mln depending on demand
Investments and investor services
Turnaround group Melrose received valid acceptances for its offer for GKN representing around 52.43% of the voting rights
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at some of the biggest risers and fallers in London on Monday
The AIM-listed healthcare IP commercialisation group said the partnership would bring Wanda’s specialities in predictive analytics and artificial intelligence (AI) to bear on orthopaedics
Investments and investor services
FTSE 100 closed down 121 points at 7,042, joining other European benchmarks, which saw red
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the biggest risers and fallers in London on Tuesday
The AIM-listed firm said the partnership will enable Vortex and Bioview to create integrated workflows that will allow the collection of intact circulating tumour cells (CTCs) from blood samples to become part of the standard of care
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of today's top risers and fallers in London today
The NEATstik test, registered with a CE mark in the second half of 2017, was sold to a research laboratory conducting a respiratory clinical trial for a pharmaceutical company
Investments and investor services
The UK's blue-chip index closes up 20.84 points to 7,234.81
Archive
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the biggest risers and fallers in London on Friday
The AIM listed transatlantic healthcare IP commercialisation group said the peer reviewed report, titled "Evaluation of PD-L1 expression on vortex-isolated circulating tumor cells in metastatic lung cancer" describes the use of Vortex's tec
The US rally fizzled out prompting a late sell-off in an already below-water London
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at some of the top risers and fallers in London today
"We are encouraged by the first commercial sales of Vortex's VTX-1 Liquid Biopsy System and the continued expansion of ProAxsis' assay portfolio,” said Francois Martelet, the chief executive officer of NetScientific
Investments and investor services
London’s blue-chip benchmark closed around 13 points lower on the day at 7,755
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the top risers and fallers in London today
The award of the CE mark means the plasmin immunoassay conforms with various EU health, safety and environmental standards and is safe for sale within Europe
London's top tier index closed down nearly 28 points at 7,696
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Some of the main news-driven risers and fallers in London on Thursday...
The trial showed that the HCC Panel was able to determine whether or not a patient had liver cancer with a “high predictability”
Investments and investor services
If you happen to work for a FTSE 100 company, your boss has already earned more in the past two-and-a-half days then the average UK employee will this year
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
The trading update was short and sweet. Liberum responded by increasing its target price.
Netscientific said the patents will significantly extend protection for the core technology used in Wanda's software application for remote health and patient management
Robert Walters sprang a pleasant surprise on the market with an unscheduled trading update.
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at some of the biggest risers and fallers in the London market today
The AIM-listed transatlantic healthcare IP commercialisation group added that ProAxsis also expects total revenue to surpass £1mln in 2018
The FTSE 100 managed to turn away from earlier losses to edge slightly higher at the close
Archive
A round-up of the days news from the small caps universe
VTX-1 is a fully automated benchtop system for collecting intact Circulating Tumour Cells (CTCs) for analysis
Archive
A glance at the stories appearing on the Proactive newswire today
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the top risers and fallers in London today
Having IP protection for HCC Panel in China is an important milestone for Glycotest, with the country having a notoriously high liver cancer death rate
The FTSE 100 closed out Thursday up around 67 points at 7,555.
The Nature Partner Journals article examines how the breakthrough VTX-1 machine helps in the process of optimising workflows
Archive
A glance at some of the day's highlights from the Proactive Investors newswire